Broadening treatment perspectives of schizophrenia: a clinical update on seroquel

Author： Fleischhacker W.W.  

Publisher： Elsevier

ISSN： 0924-977X

Source： European Neuropsychopharmacology, Vol.5, Iss.3, 1995-09, pp. : 189-189

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-Acting Injectable Risperidone for the Treatment of Schizophrenia: Clinical Perspectives

By Möller Hans-Jürgen  

Drugs, Vol. 67, Iss. 11, 2007-01 ,pp. : 1541-1566

Adis International

Access to resources Recommend Favorite

Seroquel TM treatment of hospitalised patients with acute exacerbation of subchronic or chronic schizophrenia. A multicentre, placebo-controlled, double-blind comparison of low and high dosage regimens

By Link C.G.G.   Arvanitis L.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 346-347

Elsevier

Access to resources Recommend Favorite

Sertindole: pharmacological and clinical profile and role in the treatment of schizophrenia

By Spina Edoardo   Zoccali Rocco  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 5, 2008-05 ,pp. : 629-638

Informa Healthcare

Access to resources Recommend Favorite

Treatment-resistant schizophrenia: clinical experience with new antipsychotics

By Dufour H.   Bondolfi G.   Baumann P.   Seywert F.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 202-202

Elsevier

Access to resources Recommend Favorite

The clinical investigation of medicinal products in the treatment of schizophrenia

By  

European Neuropsychopharmacology, Vol. 8, Iss. 3, 1998-08 ,pp. : 247-252

Elsevier

Access to resources Recommend Favorite